What is it about?
This paper reviews current manufacturing for pluripotent stem cell derived products. Additionally, the review seeks to highlight key areas of research that might contribute to reducing the cost of producing pluripotent stem cell derived products.
Featured Image
Read the Original
This page is a summary of: Human pluripotent stem cell‐derived products: Advances towards robust, scalable and cost‐effective manufacturing strategies, Biotechnology Journal, November 2014, Wiley,
DOI: 10.1002/biot.201400348.
You can read the full text:
Contributors
The following have contributed to this page